| Monica Girotra, MD | |
|
30 Bergen St, Admc 12 1205, Newark, NJ 07107-3000 | |
| (973) 972-0037 | |
| (973) 972-9355 |
| Full Name | Monica Girotra |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 24 Years |
| Location | 30 Bergen St, Newark, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407933948 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 25MA08126400 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Memorial Endocrine Group | 3476444506 | 16 |
News Archive
Investigators at the Massachusetts General Hospital (MGH) Center for Regenerative Medicine and the Harvard Stem Cell Institute (HSCI) have found that Sox2 - one of the transcription factors used in the conversion of adult stem cells into induced pluripotent stem cells (iPSCs) - is expressed in many adult tissues where it had not been previously observed.
Esperion Therapeutics, the leading developer of small molecule therapies for the treatment of cardiometabolic disorders, today announced positive results of a recently completed Phase 2 clinical trial of ETC-1002 in patients with type 2 diabetes with LDL-C lowering of up to 43% compared to placebo.
AdvanSource Biomaterials Corporation, a leading developer of advanced polymer materials for a broad range of medical devices, today announced financial results for its fiscal 2010 second quarter ended September 30, 2009.
Young adults who were born prematurely show multiple biological signs of risks to future health, research from Imperial College London has found. The scientists, reporting their findings tomorrow in the journal Pediatric Research, say that the research indicates that urgent work is now needed to monitor preterm babies into adulthood to improve the detection of early signs of disease.
Researchers at Lund University in Sweden have discovered how to stop the destructive process that leads to cardiovascular disease in diabetic laboratory animals.
› Verified 2 days ago
| Entity Name | Memorial Endocrine Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558332023 PECOS PAC ID: 3476444506 Enrollment ID: O20040320000126 |
News Archive
Investigators at the Massachusetts General Hospital (MGH) Center for Regenerative Medicine and the Harvard Stem Cell Institute (HSCI) have found that Sox2 - one of the transcription factors used in the conversion of adult stem cells into induced pluripotent stem cells (iPSCs) - is expressed in many adult tissues where it had not been previously observed.
Esperion Therapeutics, the leading developer of small molecule therapies for the treatment of cardiometabolic disorders, today announced positive results of a recently completed Phase 2 clinical trial of ETC-1002 in patients with type 2 diabetes with LDL-C lowering of up to 43% compared to placebo.
AdvanSource Biomaterials Corporation, a leading developer of advanced polymer materials for a broad range of medical devices, today announced financial results for its fiscal 2010 second quarter ended September 30, 2009.
Young adults who were born prematurely show multiple biological signs of risks to future health, research from Imperial College London has found. The scientists, reporting their findings tomorrow in the journal Pediatric Research, say that the research indicates that urgent work is now needed to monitor preterm babies into adulthood to improve the detection of early signs of disease.
Researchers at Lund University in Sweden have discovered how to stop the destructive process that leads to cardiovascular disease in diabetic laboratory animals.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Monica Girotra, MD 30 Bergen St, Admc 12 1205, Newark, NJ 07107-3000 Ph: (973) 972-0037 | Monica Girotra, MD 30 Bergen St, Admc 12 1205, Newark, NJ 07107-3000 Ph: (973) 972-0037 |
News Archive
Investigators at the Massachusetts General Hospital (MGH) Center for Regenerative Medicine and the Harvard Stem Cell Institute (HSCI) have found that Sox2 - one of the transcription factors used in the conversion of adult stem cells into induced pluripotent stem cells (iPSCs) - is expressed in many adult tissues where it had not been previously observed.
Esperion Therapeutics, the leading developer of small molecule therapies for the treatment of cardiometabolic disorders, today announced positive results of a recently completed Phase 2 clinical trial of ETC-1002 in patients with type 2 diabetes with LDL-C lowering of up to 43% compared to placebo.
AdvanSource Biomaterials Corporation, a leading developer of advanced polymer materials for a broad range of medical devices, today announced financial results for its fiscal 2010 second quarter ended September 30, 2009.
Young adults who were born prematurely show multiple biological signs of risks to future health, research from Imperial College London has found. The scientists, reporting their findings tomorrow in the journal Pediatric Research, say that the research indicates that urgent work is now needed to monitor preterm babies into adulthood to improve the detection of early signs of disease.
Researchers at Lund University in Sweden have discovered how to stop the destructive process that leads to cardiovascular disease in diabetic laboratory animals.
› Verified 2 days ago
Dr. Xiaoning Joanie Zhu, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 741 Broadway, Newark, NJ 07104 Phone: 973-481-1300 | |
Lissette Maria Cespedes, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 185 S Orange Ave, Msb I588, Newark, NJ 07103 Phone: 973-972-3479 | |
Dr. Pankaja Achar, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 194 Clinton Ave Fl 2, Newark, NJ 07108 Phone: 973-273-1515 Fax: 973-230-0883 | |
Marc H. Lavietes, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 90 Bergen St, Doc 4500, Newark, NJ 07103 Phone: 973-972-2500 Fax: 973-972-2510 | |
Dr. Hoi-wing Susanna Yim, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 111 Central Ave, Newark, NJ 07102 Phone: 973-877-5000 | |
Tharakeswari Selvakumar, MD, PHD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 150 Bergen St # Uhi-248, Newark, NJ 07103 Phone: 973-972-6056 | |
Dr. Epifania Lopez Ramirez, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1119 Broad St, Newark, NJ 07114 Phone: 973-824-8226 Fax: 973-824-0193 |